Merck is suing the Department of Health and Human Services over Medicare’s new powers to reduce drug prices under the Inflation Reduction Act. In a scathing complaint filed in federal district court, Merck criticized the negotiation process as a “false” and “amounting to extortion.” Merck has asked the US District Court for the District of Columbia to prevent HHS from forcing the company into a deal that cuts prices. Jakub Porzycki | Nur picture | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare’s new powers…
Read More